Measuring What Matters - Day 2

Description

Measuring what Matters in Social Determinants of Health for Chronic Illness

There is a known association between social determinants of health (SDoH) and chronic disease disparities, and between chronic disease and health related quality of life (HRQL). Far less is known about associations among SDoH, chronic disease and health outcomes, including HRQL. This symposium proposes to highlight conceptual relationships among these concepts and stimulate research ideas, including novel methodologies to analyze relationships between SDoH and HRQL for people with chronic illness.

View full program here.

DAY TWO

Session 4: Research in Chronic Conditions
This session will follow a series of clinical and public health research presentations documenting the relationship between SDoH and HRQL for individuals living with diverse chronic illnesses.
Objective:

Based on research, learn how SDoH applies to HRQL and health outcomes in persons with cardiovascular disease, autoimmune inflammatory disorders, mental illness, and for transgender and gender-diverse individuals.

Speakers:

Justin Abbatemarco, MD, Assistant Professor at the Cleveland Clinic Lerner College of Medicine, Staff Physician at the Mellen Center, United States
Foster Osei Baah, MS-PhD RN, Assistant Professor, Emory University, United States
Jan R. Boehnke, PhD, Reader, University of Dundee, United Kingdom
Manraj Kaur, PhD, Investigator, Brigham and Women’s Hospital, Harvard Medical School, United States

Session 5: Implementation Science: Application to Clinical Care and Policy
Short presentations will discuss the realities of addressing SDoH, controversies related to SDoH including who is responsible for delivering interventions (communities, health care providers, health organizations/systems, health insurers, government agencies) and how implementation science can guide the translation of SDoH into practice and policy. A moderated Q&A and audience Q&A will follow to close out the event.
Objectives:

Discuss who is responsible for driving policy delivering interventions
Understand how implementation science can guide translation of SDoH research into practice and policy

Speakers:

David Chambers, D.Phil, Deputy Director for Implementation Science, National Cancer Institute, United States
J. Gmerice Hammond, MD MPH, Cardiologist at Washington University School of Medicine, United States
Jeff Micklos, Executive Director, Health Care Transformation Task Force, United States

Contributors

Justin Abbatemarco, MD, Assistant Professor at the Cleveland Clinic Lerner College of Medicine, Staff Physician at the Mellen Center, United States

Dr. Justin Abbatemarco, MD is an Assistant Professor at the Cleveland Clinic Lerner College of Medicine and a Staff Physician at the Mellen Center. He graduated from the Cleveland Clinic neurology residency where he served as Chief Resident and is dual fellowship trained in neuroimmunology from the Cleveland Clinic Mellen Center and autoimmune neurology from the University of Utah. He is board certified in Neurology from the American Board of Psychiatry and Neurology (ABPN). As Director of Inpatient General Neurology at Cleveland Clinic, he enhances patient care and educates future medical professionals. In his outpatient clinic, he specializes in managing central nervous system inflammatory disorders. Dr. Abbatemarco also contributes to the field as a member of ABPN's Behavioral Neurology, Cognition, and Psychiatry Test Writing Committee and the AAN Graduate Education Committee. His research focuses on neuroinflammatory disorders and health disparities.
Jan R. Boehnke, PhD, Reader, University of Dundee, United Kingdom

Jan R. Boehnke, PhD, is a Reader in the School of Health Sciences at the University of Dundee (UK). His research focuses on the connections between mental and physical health, especially for people living with severe mental illnesses. He uses patient-reported outcome data collected in a variety of settings to investigate the differential impacts of conditions as well as the cumulative burden associated with them. As a research methodologist, Dr. Boehnke is interested in modern psychometric and statistical techniques, and has in recent years worked on core outcome sets and their dissemination. He is Co-Editor in Chief of Quality of Life Research.
David Chambers, D.Phil, Deputy Director for Implementation Science, National Cancer Institute, United States

Dr. David Chambers is Deputy Director for Implementation Science in the Office of the Director in the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). Dr. Chambers manages a team focusing on efforts to build and advance the field of Implementation Science (IS) through funding opportunities, training programs, research activities, dissemination platforms, and enhancement of partnerships and networks to integrate research, practice and policy. Prior to his arrival at NIH, Dr. Chambers worked as a member of a research team at Oxford University, where he studied national efforts to implement evidence-based practice within healthcare systems. He publishes on strategic research directions in implementation science and serves as a plenary speaker at numerous scientific conferences. He received his A.B. degree (with Honors) in Economics from Brown University in 1997, and an M.Sc. and D.Phil degree in Management Studies (Organisational Behaviour) in 1998 and 2001, respectively, from Oxford University (UK).
J. Gmerice Hammond, MD MPH, Cardiologist at Washington University School of Medicine, United States

Dr. Hammond is a cardiologist and health services and policy researcher at Washington University in St Louis. The goal of her research is to reduce inequities in cardiovascular disease. Specifically, her work examines the role that health policy implementation plays in race and socioeconomic-based inequities in cardiovascular disease outcomes. Her current work is focused on gaining a better understanding of how payment policies influence the implementation strategies used to manage high-risk, high-cost conditions for populations made socially vulnerable due to systemic and structural violence, specifically racism and chronic socioeconomic deprivation.
Manraj Kaur, PhD, Investigator, Brigham and Women’s Hospital, Harvard Medical School, United States

Dr. Manraj Kaur (She/Her) is an Investigator and Lead Faculty for Research and Innovation at the Patient-Reported Outcomes, Value, and Experience (PROVE) Center, situated in the Department of Surgery at Brigham and Women’s Hospital, Boston. Holding a cross-appointment at Harvard Medical School, Dr. Kaur is committed to integrating patient perspectives into clinical decision-making and quality improvement initiatives. Specializing in patient-reported outcome measurement, her research, especially within minority and underserved communities, aims to enhance person-centered clinical care. Dr. Kaur earned her doctoral and Master’s degrees in Rehabilitation Science with a health economics and outcomes research focus from McMaster University in Canada. Her research has been funded by the National Institutes of Health, Canadian Institutes for Health Research and the Canadian Cancer Society.
Jeff Micklos, Executive Director, Health Care Transformation Task Force, United States

Jeff Micklos is the Executive Director of the Health Care Transformation Task Force. An attorney by training, Jeff is the former Executive Vice President, Management, Compliance, & General Counsel of the Federation of American Hospitals, a national trade association representing investor-owned hospitals, and a former Partner in the Health Law Department of the international law firm of Foley & Lardner LLP. Mr. Micklos began his career as a litigator and regulatory counsel for the Health Care Financing Administration, U.S. Department of Health and Human Services, and also served in the Office of General Counsel of the Social Security Administration. Jeff is a graduate of the Columbus School of Law, The Catholic University of America, and received a Bachelor Arts Degree from Villanova University. He resides in Washington, DC with his wife, Monica, and their four children.
Foster Osei Baah, MS-PhD RN, Assistant Professor, Emory University, United States

Foster Osei Baah, PhD, RN is a cardiovascular nurse scientist with a program of research focused on the social determinants of cardiovascular health behavior, self-care, cardiometabolic disease and cardiovascular health disparities in marginalized groups. The fundamental goal of this research program is to inform, design, and test interventions that enhance health behavior, improve health outcomes, and promote equity across diverse population groups. Prior to joining the Nell Hodgson Woodruff School of Nursing as a Tenure Track Assistant Professor, he completed a PhD in Nursing Science at the University of Pennsylvania and postdoctoral fellowship at the Social Determinants of Obesity and Cardiovascular Risk Laboratory at the National Heart, Lung, and Blood Institute (NHLBI) with a focus on intervention design to address obesity and cardiovascular health disparities in resource limited neighborhoods.

Description

Measuring what Matters in Social Determinants of Health for Chronic Illness

Contributors

Justin Abbatemarco, MD, Assistant Professor at the Cleveland Clinic Lerner College of Medicine, Staff Physician at the Mellen Center, United States

Jan R. Boehnke, PhD, Reader, University of Dundee, United Kingdom

David Chambers, D.Phil, Deputy Director for Implementation Science, National Cancer Institute, United States

J. Gmerice Hammond, MD MPH, Cardiologist at Washington University School of Medicine, United States

Manraj Kaur, PhD, Investigator, Brigham and Women’s Hospital, Harvard Medical School, United States

Jeff Micklos, Executive Director, Health Care Transformation Task Force, United States

Foster Osei Baah, MS-PhD RN, Assistant Professor, Emory University, United States